COMMUNIQUÉS West-GlobeNewswire

Pixium Vision annonce ses résultats financiers au 30 juin 2019 et fait le point sur ses activités
25/07/2019
Confirmation de résultats cliniques meilleurs qu’attendus à 12 mois avec le système Prima Mise en œuvre d’un plan d’action auprès des autorités réglementaires pour définir le plan de développement du système Prima aux [...]
Roche reports very strong performance in the first half of 2019 – Outlook raised
25/07/2019
Basel, 25 July 2019 Group sales increase 9% 1 at constant exchange rates and 8% in Swiss francs Pharmaceuticals Division sales up 10%, driven mainly by Ocrevus, Hemlibra, Tecentriq and Perjeta Diagnostics Division sales [...]
Roche affiche une très bonne performance au premier semestre 2019 – prévisions pour l’année révisées à la hausse
25/07/2019
Bâle, le 25 juillet 2019 Le chiffre d’affaires consolidé augmente de 9% 1 à taux de change constants et de 8% en francs suisses Le chiffre d’affaires de la division Pharma est en hausse de 10%, porté principalement par [...]
Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China
25/07/2019
PISCATAWAY, N.J., July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta), a technology based company focusing on the development and commercialization of Branded Specialty Products, today announced that [...]
MediciNova Appoints Kazuko Matsuda to its Board of Directors
25/07/2019
LA JOLLA, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Cara Therapeutics Announces Pricing of $126.5 Million Offering of Common Stock
25/07/2019
STAMFORD, Conn., July 24, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
Livongo Announces Pricing of Initial Public Offering
25/07/2019
MOUNTAIN VIEW, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (Livongo) today announced the pricing of its initial public offering of 12,687,000 shares of its common stock at a price of $28.00 per share [...]
Ascent Industries Announces That David Kennedy Joins as Operations Director-Nevada
25/07/2019
VANCOUVER, British Columbia, July 24, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. (CSE: ASNT) (“Ascent”) announces David Kennedy is joining the new management team to lead operations at the Las Vegas, Nevada [...]
Roxadustat China Phase 3 Trial for Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine (NEJM)
25/07/2019
-- One of Two Concurrent Publications of Roxadustat China Phase 3 Results in The New England Journal of Medicine -- SAN FRANCISCO, July 24, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced [...]
The New England Journal of Medicine (NEJM) Publishes Roxadustat China Phase 3 Results for the Treatment of Anemia in Chronic Kidney Disease Patients Receiving Dialysis
25/07/2019
-- One of Two Concurrent Publications of Roxadustat China Phase 3 Results in The New England Journal of Medicine -- SAN FRANCISCO, July 24, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the [...]
Helix Biopharma Corp. to Present at RHK Capital Conference in New York
24/07/2019
RICHMOND HILL, Ontario, July 24, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
American Pharmacies Uses FDS Analytics to Help Win $2 Fee Increase in New Mexico Medicaid
24/07/2019
FORT WORTH, Texas, July 24, 2019 (GLOBE NEWSWIRE) -- FDS Inc. today announced that New Mexico pharmacies scored an important political and financial win thanks to comprehensive analytics generated by American Pharmacies [...]
Alphatec Reports Second Quarter 2019 Financial Results and Corporate Highlights
24/07/2019
Full Year 2019 Revenue Guidance Increased Following 28% Q2 U.S. Revenue Growth CARLSBAD, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of [...]
SI-BONE to Present at the Canaccord Growth Conference on August 8, 2019
24/07/2019
SANTA CLARA, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management [...]
Aeglea BioTherapeutics Receives FDA Breakthrough Therapy Designation for Pegzilarginase for Treatment of Arginase 1 Deficiency
24/07/2019
Designation Follows Recently Reported ARG1-D Phase 1/2 Data Demonstrating Clinical Response in Patients Treated with Pegzilarginase AUSTIN, Texas, July 24, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: [...]
Chembio Diagnostics to Participate in the Canaccord Genuity Growth Conference
24/07/2019
MEDFORD, N.Y., July 24, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the company plans to participate in [...]
LeMaitre Vascular Announces Q2 2019 Financial Results
24/07/2019
BURLINGTON, Mass., July 24, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2019 results, provided guidance, and announced a $0. [...]
Align Technology Announces Second Quarter 2019 Financial Results
24/07/2019
Achieves 7 Millionth Invisalign Patient Milestone Q2 revenues up 22.5% year-over-year to a record $600.7 million Q2 Invisalign volume up 24.6% year-over-year to 377.1 thousand cases Q2 scanner and services revenues up [...]
Dynavax Technologies to Report Second Quarter 2019 Financial Results and Host Conference Call on August 7
24/07/2019
BERKELEY, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on developing novel vaccines, will report its second quarter 2019 [...]

Pages